TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Generic drugmaker Mylan completes $1.75B acquisition in India

On the Grid

From the shale fields to the cooling towers, Trib Total Media covers the energy industry in Western Pennsylvania and beyond. For the latest news and views on gas, coal, electricity and more, check out On the Grid today.

Thursday, Dec. 5, 2013, 12:01 a.m.
 

Generic drugmaker Mylan Inc. expanded its global manufacturing capability and portfolio of injectable medications with a $1.75 billion acquisition on Wednesday.

Cecil-based Mylan, one of the world's biggest generic pharmaceutical companies, said it completed the purchase of the Agila unit of Indian drugmaker Strides Arcolab Ltd.

The deal, first announced in February, gives Mylan 13 manufacturing plants in six countries and four research and development centers staffed by 400 scientists.

The addition of Agila's portfolio means Mylan offers more than 1,200 injectable drugs across the world, with another 900 products awaiting regulatory approvals, the company said.

Agila's foothold in several emerging markets, including Brazil, India and Southeast Asia, was attractive to Mylan.

“The acquisition of Agila will create a global injectables leader, expanding and strengthening Mylan's existing injectables platform and portfolio, and providing Mylan entry into exciting, new geographic markets,” CEO Heather Bresch said in a statement. “We believe we can generate significant growth from this business.”

Mylan will hold back $250 million in the deal on the condition that Agila satisfy U.S. regulators over problems of one of its Indian manufacturing plants.

In September, the Food and Drug Administration sent a so-called warning letter to Agila as a result of a June inspection at its Bangalore factory that turned up deficient procedures for preventing contamination of products.

Alex Nixon is a staff writer for Trib Total Media. He can be reached at 412-320-7928 or anixon@tribweb.com.

Add Alex Nixon to your Google+ circles.

 

 

 
 


Show commenting policy

Most-Read Business Headlines

  1. Amusement parks fight off home entertainment threat
  2. Caution creeps into economic picture as consumer, business spending taper
  3. S&P 500 logs 47th record high close for year
  4. State officials prompt UPMC, Highmark to go to mediation to resolve Medicare dispute
  5. Federal agency checking whether Highmark has enough doctors in Medicare plan
  6. Retailers that won’t open on Thanksgiving hope move pays off
  7. BNY Mellon trader fired in conduct probe
  8. Westinghouse to construct colossal nuke plant in Turkey
  9. Westinghouse CEO expects nuclear power to grow in energy-hungry U.S.
  10. Alcoa moves into 3-D printing for part manufacturing
  11. Kia’s 1st electric vehicle charges fast, goes distance
Subscribe today! Click here for our subscription offers.